IVI and Denmark
Dr. Lars Pallesen of the Statens Seruminstitut & Danish Pharmaceutical Association was a founding leader of IVI and served on the Board of Trustees from 1995 to 2001.
In December 2020, IVI began its partnership with ICARS through a jointly-hosted webinar titled “Advancing the Antimicrobial Resistance agenda during a pandemic.” Officials from ICARS, IVI and the Embassy of Denmark in Korea offered strategies to tackle AMR and improve evidence and data collection in low- and middle-income countries where this issue poses a particularly large threat.
In early 2020, the Technical University of Denmark’s National Food Institute partnered with IVI to establish EQASIA, a Fleming Fund-backed project aiming to improve the quality of bacteriology diagnostics in Asia and avert the human and economic burden of AMR. After IVI mapped the coverage, availability and uptake of EQA across One Health sector national reference labs in Asia, the collaborators provided facilities with EQA services and other relevant training resources. Moving forward, IVI and the Technical University of Denmark’s Food Institute are implementing QM training and distributing AMR test panels to regional laboratories in Asia.